![]()
|
Report Date : |
05.09.2008 |
IDENTIFICATION
DETAILS
|
Name : |
POPULAR PHARMACEUTICALS LIMITED |
|
|
|
|
Registered Office : |
164,
Tongi Industrial Area, Tongi,
Gazipur-1711, Dhaka, |
|
|
|
|
Country : |
Bangladesh |
|
|
|
|
Date of Incorporation : |
08.12.2002 |
|
|
|
|
Com. Reg. No.: |
C-47852 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturer & Sellers of Drugs & Medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Name: Popular
Pharmaceuticals Limited
Address: 164, Tongi Industrial Area,
Tongi,
Gazipur-1711
Dhaka,
Country: Bangladesh
Tel No : 880-2-9812971-5
Fax No : 880-2-9812976
E-Mail: popular@citechco.net
Established: December 2002
Incorporation
No: C-47852
Incorporation
Date: 8th December 2002
Legal Structure: The subject is a Private
Limited Company that was
Incorporated in the Registrar of
Joint Stock of
Companies, Dhaka.
Business Type: Manufacturer & Sellers
Status: Satisfactory
Payments: No complaints have
been heard regarding payments
from local suppliers or banks.
Litigation: NIL
Head Office: House. 25,
Road, 2,
Dhanmondi,
Dhaka – 1205,
Tel No: 880-2-9669301-5
Fax No:
880-2-9675633
E-Mail: popular@citechco.net
Sales Centre: 1 Chittagong
1 Sylhet
1 Bogra
1 Khulna
1 Rangpur
1 Barishal
1 Comilla
1 Cox’s Bazar
1 Jessore
1 Mymensing
1 Faridpur
Factory: 164, Tongi Industrial
Area,
Tongi,
Gazipur-1711
Dhaka,
Warehouse: 164, Tongi Industrial
Area,
Tongi,
Gazipur-1711
Dhaka,
Name: Dr.Mustafizur
Rahman
Designation: Chairman &
Managing Director
Name: Mr.Nazim Ferdous
Designation: Director
Line of Business:
Manufacturer & Sellers
Items Dealing In: Drugs &
Medicines
Terms of Sale: 1 Cash
1 Credit
Name: Standard Chartered
Bank
Branch: Main Branch
Address: Dilkusha
Commercial Area,
Dhaka
The company performs most of the business transactions with the
above-mentioned bank. No more details were provided.
|
|
2007 |
2006 |
2005 |
|
Capital Invested |
Tk.25 million |
Tk.25 million |
Tk.25 million |
|
Turnover |
Tk.150 million |
Tk.148.7 million |
Tk.147 million |
|
Liability |
NIL |
NIL |
NIL |
|
Fixed Assets |
Tk.45 million |
Tk.45 million |
Tk.45 million |
|
Authorized Capital |
: |
Tk.100 million |
|
Paid Up Capital |
: |
Tk.500, 000.00 |
|
Each Share Value |
: |
Tk.100.00 |
|
CURRENCY |
UNIT |
BANGLADESHI TAKA |
|
Great Britain Pound |
1 |
137.1626 |
|
U.S Dollar |
1 |
69.4000 |
|
European Euro |
1 |
108.8231 |
|
Japanese Yen |
1 |
0.6729 |
|
Australian Dollar |
1 |
65.7102 |
No. of Employees: 332
Executives-----------------4
Junior Executives--------10
Pharmacist----------------4
Chemist-------------------3
Engineers-----------------2
Sales Staffs------------- 10
Quality
Control---------- -8
Supervisory
Staffs-------15
Support
Staffs-------------4
General
Staffs------------10
Technicians----------------4
Workers-----------------258
Range of Products: 1 Tablets
1 Capsules
1 Suspensions
1 Injections
1 Eye Drops
1 Creams
1 Ointments
1 Animal Drugs
Office Area: 1,250 sq.ft (own)
Factory Area: 18,000 sq.ft (own)
Warehouse Area: 3,900 sq.ft.(own)
Major Clients: 1 Central Medical Store
Depot, Bangladesh Government
1 Bangladesh Army
1 Bangladesh Rifles
1 Police Hospital
1 BIRDEM
1 Chittagong Medical College &
Hospital
1 M.A.G. Osmani Medical College &
Hospital Sylhet
1 HCDP (Health care Development
project)
1 Apollo
Hospitals
1 United Hospital
1 Square
Hospitals Ltd
1 Labaid Cardiac
Hospital
1 Lab Aid Specialized Hospital
Raw Materials From: 1 EEC Countries
1 China
1 Korea
1 Singapore
1 Pakistan
1 India
1 Australia
1 Taiwan
Name of the Group: NIL
Subsidiaries: 1 Popular Diagnostic Centre
1 Popular
Infusions Limited
Member: 1 Bangladesh Association of Pharmaceuticals,
Dhaka
1 Dhaka Chamber of Commerce &
Industries, Dhaka
The subject is a private limited company who is engaged in manufacturing
and selling of drugs and medicines. The company’s factory is most modern and
the quality of their products is of international standard. Their products are
popular and sold all over the country.
The directors are well conversant in their line of trade and
they are also experienced businessman. They are financially solvent and good at
their business commitments, it is reported.
The company is good for normal business engagements.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.26 |
|
UK Pound |
1 |
Rs.79.19 |
|
Euro |
1 |
Rs.64.42 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)